264 related articles for article (PubMed ID: 23677912)
1. Acquired hemophilia a: retrospective analysis of 49 cases from a single Chinese hemophilia center.
Yang Y; Xue F; Shi H; Wang H; Zhang L; Ji L; Yang R
Clin Appl Thromb Hemost; 2015 Jan; 21(1):35-40. PubMed ID: 23677912
[TBL] [Abstract][Full Text] [Related]
2. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of acquired inhibitors of coagulation factors].
Koyama T
Rinsho Ketsueki; 2014 Jan; 55(1):67-74. PubMed ID: 24492039
[No Abstract] [Full Text] [Related]
4. Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China.
Ye N; Liu Z; Xu G; Wang X; Wu F; Xu X; Wu W
Hematology; 2019 Dec; 24(1):631-636. PubMed ID: 31514689
[No Abstract] [Full Text] [Related]
5. Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.
Ogawa Y; Yanagisawa K; Uchiumi H; Ishizaki T; Mitsui T; Gouda F; Ieko M; Ichinose A; Nojima Y; Handa H
Int J Hematol; 2017 Jul; 106(1):82-89. PubMed ID: 28299631
[TBL] [Abstract][Full Text] [Related]
6. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.
Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J
Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513
[TBL] [Abstract][Full Text] [Related]
7. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
9. Acquired hemophilia.
Bouvry P; Recloux P
Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
[TBL] [Abstract][Full Text] [Related]
10. Acquired factor VIII inhibitors.
Franchini M; Lippi G
Blood; 2008 Jul; 112(2):250-5. PubMed ID: 18463353
[TBL] [Abstract][Full Text] [Related]
11. Acquired inhibitors of coagulation factors: part I-acquired hemophilia A.
Coppola A; Favaloro EJ; Tufano A; Di Minno MN; Cerbone AM; Franchini M
Semin Thromb Hemost; 2012 Jul; 38(5):433-46. PubMed ID: 22740182
[TBL] [Abstract][Full Text] [Related]
12. Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases.
Berezné A; Stieltjes N; Le-Guern V; Teixeira L; Billy C; Roussel-Robert V; Flaujac C; Horellou MH; Guillevin L; Mouthon L
Transfus Med; 2006 Jun; 16(3):209-12. PubMed ID: 16764602
[TBL] [Abstract][Full Text] [Related]
13. Hemophilia. Strategies for the treatment of inhibitor patients.
Ingerslev J
Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
[TBL] [Abstract][Full Text] [Related]
14. New protocol for immune tolerance induction in acquired hemophilia.
Nemes L; Pitlik E
Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
[TBL] [Abstract][Full Text] [Related]
15. Outcome of CARE: a 6-year national registry of acquired haemophilia A in China.
Sun B; Xue F; Feng Y; Sun J; Yu Z; Hou M; Zhang J; Zeng X; Zhao Y; Lian S; Huang M; Niu T; Cui Z; Wu J; Yang R
Br J Haematol; 2019 Dec; 187(5):653-665. PubMed ID: 31372978
[TBL] [Abstract][Full Text] [Related]
16. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].
Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E
Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386
[TBL] [Abstract][Full Text] [Related]
17. [Acquired haemophilia (acquired factor VIII inhibitor)].
Ceresetto JM; Duboscq C; Fondevila C; Tezanos Pinto M
Medicina (B Aires); 2015; 75(4):231-8. PubMed ID: 26339881
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.
Ay Y; Balkan C; Karapinar DY; Akin M; Bilenoglu B; Kavakli K
Clin Appl Thromb Hemost; 2013; 19(4):389-94. PubMed ID: 22395575
[TBL] [Abstract][Full Text] [Related]
19. Acquired factor VIII inhibitor as initial manifestation of collagen vascular disease: response to combination immunosuppression as first-line therapy.
Wilson B; Means RT
Am J Med Sci; 2011 Jul; 342(1):70-2. PubMed ID: 21412135
[TBL] [Abstract][Full Text] [Related]
20. A study of 65 patients with acquired hemophilia A in Taiwan.
Huang SY; Tsay W; Lin SY; Hsu SC; Hung MH; Shen MC
J Formos Med Assoc; 2015 Apr; 114(4):321-7. PubMed ID: 25839765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
